Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business software deal

Amgen Deploys Veeva Vault CRM Globally

Analysis based on 14 articles · First reported Sep 15, 2026 · Last updated Sep 23, 2026

Sentiment
5
Attention
2
Articles
14
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The deal is a modest positive for Veeva Systems as it locks in a major global pharmaceutical customer for its next-generation CRM platform, reinforcing recurring revenue and competitive positioning in life sciences software. For Amgen, the impact is operational rather than financial, with the platform intended to improve commercial execution and therapy launch efficiency without materially altering near-term earnings expectations.

pharmaceuticals software healthcare technology

Veeva Systems announced on September 15, 2026 that Amgen plans to deploy Veeva Vault CRM globally, expanding a collaboration between the two companies that spans more than a decade. Vault CRM is part of the Vault CRM Suite, described by Veeva as an agentic commercial foundation designed to transform how life sciences companies engage with healthcare professionals, accelerate launch performance, and improve patient outcomes. The platform includes the Agentic Call Report, which generates commercial evidence and helps uncover previously hidden treatment barriers. Scott Skellenger, senior vice president and chief information officer at Amgen, said the move to Vault CRM will help accelerate efforts to bring new therapies to patients globally with greater speed and agility, citing Veeva's deep understanding of life sciences and continued focus on innovation. Matt Farrell, president of commercial strategy at Veeva, said Vault CRM will provide the agentic commercial foundation to help Amgen deliver innovative medicines for some of the world's toughest diseases to millions of patients. Veeva, a Public Benefit Corporation, serves more than 1,500 customers ranging from emerging biotechs to the world's largest pharmaceutical companies. The announcement is a commercial software selection rather than a merger or acquisition, and financial terms were not disclosed. VEEV shares closed at $266.62, up 0.36 percent, on the Tuesday preceding one of the reports, with the stock having traded between $148.05 and $310.50 over the prior year.

70 Veeva Systems announced new commitment
65 Amgen selected Veeva Vault CRM Veeva Systems
40 Biogen selected Vault CRM Veeva Systems
40 Eli Lilly and Company selected Vault CRM Veeva Systems
stock
Veeva Systems is the provider whose Vault CRM platform was selected by Amgen, expanding a decade-long partnership and validating its agentic commercial strategy. The deal supports Veeva's recurring revenue base and competitive position in life sciences software, a modest positive for the stock.
Importance 90.0 Sentiment 25.0
stock
Amgen plans to deploy Veeva Vault CRM globally to accelerate delivery of new therapies and improve commercial execution across markets. The move is an operational upgrade with limited near-term financial impact but supports long-term launch efficiency.
Importance 85.0 Sentiment 10.0
per
Scott Skellenger, Amgen's senior vice president and chief information officer, commented that Vault CRM will help accelerate bringing new therapies to patients with greater speed and agility. He is a spokesperson for the decision rather than a party whose own financial state is affected.
Importance 20.0 Sentiment 0.0
per
Matt Farrell, Veeva's president of commercial strategy, said Vault CRM will provide the agentic commercial foundation for Amgen's therapy launches. He represents Veeva in the announcement and is not independently financially affected by the event.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.